Guizhou Yue Selected Research

Guizhou Yue Research Topics

Disease

6	Infections 07/2021 - 01/2016
4	Neoplasms (Cancer) 12/2023 - 01/2020
3	Inflammation (Inflammations) 01/2018 - 06/2017
2	Wiskott-Aldrich Syndrome 05/2023 - 07/2022
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2023 - 06/2020
2	Poisoning 11/2022 - 07/2022
2	Diarrhea 01/2018 - 01/2017
1	Hypoxia (Hypoxemia) 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Ovarian Neoplasms (Ovarian Cancer) 06/2020
1	Edema (Dropsy) 01/2018
1	Pain (Aches) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2017
1	Tinea (Ringworm) 01/2017
1	Body Weight (Weight, Body) 04/2016
1	Enteritis 01/2016
1	Dandruff 01/2015

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 05/2023 - 06/2020
3	Antiviral Agents (Antivirals)IBA 07/2021 - 01/2016
3	VaccinesIBA 07/2021 - 01/2016
3	ResveratrolIBA 01/2018 - 01/2016
2	pedunsaponin AIBA 05/2023 - 11/2022
2	Protein Isoforms (Isoforms)IBA 05/2023 - 07/2022
2	AlkaloidsIBA 01/2023 - 01/2021
2	DiterpenesIBA 01/2023 - 01/2021
2	AconitineIBA 01/2023 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2020 - 01/2015
2	Galla chinensisIBA 01/2018 - 01/2017
2	CytokinesIBA 01/2018 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 05/2016
1	Free RadicalsIBA 12/2023
1	Metal-Organic FrameworksIBA 12/2023
1	CatalaseIBA 12/2023
1	Glutathione (Reduced Glutathione)IBA 12/2023
1	Peroxidase (Myeloperoxidase)IBA 12/2023
1	Sulfides (Thioethers)IBA 12/2023
1	Superoxide DismutaseIBA 12/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	EstersIBA 01/2023
1	Hydroxyl RadicalIBA 01/2023
1	Linoleic Acid (Linoleate)IBA 01/2023
1	AlginatesIBA 07/2022
1	HemocyaninsIBA 07/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2021
1	kaempferolIBA 07/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2018
1	CarrageenanIBA 01/2018
1	InterferonsIBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	SuspensionsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Interferon-alpha (Interferon Alfa)IBA 01/2018
1	Endothelial Protein C ReceptorIBA 06/2017
1	activated protein C receptorIBA 06/2017
1	Protein CIBA 06/2017
1	Castor Oil (Oil, Castor)IBA 01/2017
1	Charcoal (Charbon)IBA 01/2017
1	AntidiarrhealsIBA 01/2017
1	SolutionsIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2016

Therapy/Procedure

2	Therapeutics 12/2023 - 01/2021
1	Drug Therapy (Chemotherapy) 06/2020